Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 191

1.

Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy.

Das M, Karnam A, Stephen-Victor E, Gilardin L, Bhatt B, Kumar Sharma V, Rambabu N, Patil V, Lecerf M, Käsermann F, Bruneval P, Narayanaswamy Balaji K, Benveniste O, Kaveri SV, Bayry J.

Cell Death Dis. 2020 Jan 23;11(1):50. doi: 10.1038/s41419-020-2249-y.

2.
4.

Anti-IgE IgG autoantibodies isolated from therapeutic normal IgG intravenous immunoglobulin induce basophil activation.

Galeotti C, Karnam A, Dimitrov JD, Chevailler A, Kaveri SV, Bayry J.

Cell Mol Immunol. 2019 Dec 4. doi: 10.1038/s41423-019-0334-x. [Epub ahead of print] No abstract available.

PMID:
31797906
5.

Correction: Saha, C., et al. Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4+ T Cell Responses. Molecules 2016, 21, 912.

Saha C, Das M, Stephen-Victor E, Friboulet A, Bayry J, Kaveri SV.

Molecules. 2019 Oct 18;24(20). pii: E3762. doi: 10.3390/molecules24203762.

6.

Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis.

Maddur MS, Lacroix-Desmazes S, Dimitrov JD, Kazatchkine MD, Bayry J, Kaveri SV.

Clin Rev Allergy Immunol. 2019 Jun 3. doi: 10.1007/s12016-019-08746-9. [Epub ahead of print] Review.

PMID:
31161341
7.

Anti-inflammatory activity of intravenous immunoglobulin through scavenging of heme.

Wiatr M, Merle NS, Boudhabhay I, Poillerat V, Rossini S, Lecerf M, Kaveri SV, Lacroix-Desmazes S, Roumenina LT, Dimitrov JD.

Mol Immunol. 2019 Jul;111:205-208. doi: 10.1016/j.molimm.2019.04.020. Epub 2019 May 10.

8.

Does intravenous immunoglobulin therapy in Guillain-Barré syndrome patients interfere with serological Zika detection?

Karnam A, Stephen-Victor E, Das M, Magy L, Vallat JM, Bolgert F, Simon-Loriere E, Kaveri SV, Sakuntabhai A, Bayry J.

Autoimmun Rev. 2019 Jun;18(6):632-633. doi: 10.1016/j.autrev.2019.01.004. Epub 2019 Apr 5. No abstract available.

PMID:
30959213
9.

Intravenous immunoglobulin suppresses the polarization of both classically and alternatively activated macrophages.

Saha C, Kothapalli P, Patil V, ManjunathaReddy GB, Kaveri SV, Bayry J.

Hum Vaccin Immunother. 2020;16(2):233-239. doi: 10.1080/21645515.2019.1602434. Epub 2019 May 7.

PMID:
30945973
10.

Intravenous Immunoglobulin Therapy Eliminates Candida albicans and Maintains Intestinal Homeostasis in a Murine Model of Dextran Sulfate Sodium-Induced Colitis.

Charlet R, Sendid B, Kaveri SV, Poulain D, Bayry J, Jawhara S.

Int J Mol Sci. 2019 Mar 23;20(6). pii: E1473. doi: 10.3390/ijms20061473.

11.

Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE.

Galeotti C, Stephen-Victor E, Karnam A, Das M, Gilardin L, Maddur MS, Wymann S, Vonarburg C, Chevailler A, Dimitrov JD, Benveniste O, Bruhns P, Kaveri SV, Bayry J.

J Allergy Clin Immunol. 2019 Aug;144(2):524-535.e8. doi: 10.1016/j.jaci.2018.10.064. Epub 2018 Dec 7.

12.

Intravenous immunoglobulin protects from experimental allergic bronchopulmonary aspergillosis via a sialylation-dependent mechanism.

Bozza S, Käsermann F, Kaveri SV, Romani L, Bayry J.

Eur J Immunol. 2019 Jan;49(1):195-198. doi: 10.1002/eji.201847774. Epub 2018 Oct 29.

13.

Kill 'Em All: Efgartigimod Immunotherapy for Autoimmune Diseases.

Bayry J, Kaveri SV.

Trends Pharmacol Sci. 2018 Nov;39(11):919-922. doi: 10.1016/j.tips.2018.08.004. Epub 2018 Sep 7. Review.

PMID:
30201270
14.

Catalytic antibodies in patients with systemic lupus erythematosus.

Pradhan V, Pandit P, Surve P, Lecerf M, Rajadhyaksha A, Nadkar M, Khadilkar PV, Chougule DA, Naigaonkar AA, Lacroix-Desmazes S, Bayry J, Ghosh K, Kaveri SV.

Eur J Rheumatol. 2018 Sep;5(3):173-178. doi: 10.5152/eurjrheum.2018.17194. Epub 2018 Aug 7.

15.

Regulatory T cells induce activation rather than suppression of human basophils.

Sharma M, Das M, Stephen-Victor E, Galeotti C, Karnam A, Maddur MS, Bruneval P, Kaveri SV, Bayry J.

Sci Immunol. 2018 May 25;3(23). pii: eaan0829. doi: 10.1126/sciimmunol.aan0829.

PMID:
29802207
16.

Affinity kinetics of leptin-reactive immunoglobulins are associated with plasma leptin and markers of obesity and diabetes.

Bouhajja H, Bougacha-Elleuch N, Lucas N, Legrand R, Marrakchi R, Kaveri SV, Jamoussi K, Ayadi H, Abid M, Mnif-Feki M, Fetissov SO.

Nutr Diabetes. 2018 May 24;8(1):32. doi: 10.1038/s41387-018-0044-y.

17.

Induction of human dendritic cell maturation by naïve and memory B-cell subsets requires different activation stimuli.

Maddur MS, Kaveri SV, Bayry J.

Cell Mol Immunol. 2018 Dec;15(12):1074-1076. doi: 10.1038/s41423-018-0017-z. Epub 2018 Mar 22. No abstract available.

18.

Passive Serum Therapy to Immunomodulation by IVIG: A Fascinating Journey of Antibodies.

João C, Negi VS, Kazatchkine MD, Bayry J, Kaveri SV.

J Immunol. 2018 Mar 15;200(6):1957-1963. doi: 10.4049/jimmunol.1701271. Review.

19.

Aspergillus fumigatus Cell Wall α-(1,3)-Glucan Stimulates Regulatory T-Cell Polarization by Inducing PD-L1 Expression on Human Dendritic Cells.

Stephen-Victor E, Karnam A, Fontaine T, Beauvais A, Das M, Hegde P, Prakhar P, Holla S, Balaji KN, Kaveri SV, Latgé JP, Aimanianda V, Bayry J.

J Infect Dis. 2017 Dec 5;216(10):1281-1294. doi: 10.1093/infdis/jix469.

PMID:
28968869
20.

Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin.

Maddur MS, Kaveri SV, Bayry J.

Trends Immunol. 2017 Nov;38(11):789-792. doi: 10.1016/j.it.2017.08.008. Epub 2017 Sep 12.

PMID:
28916232

Supplemental Content

Loading ...
Support Center